UK Markets close in 2 hrs 33 mins

Johnson & Johnson (JNJ)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
144.24+0.26 (+0.18%)
As of 9:57AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close143.97
Bid144.02 x 900
Ask0.00 x 800
Day's range143.70 - 144.29
52-week range109.16 - 157.00
Avg. volume5,959,472
Market cap379.745B
Beta (5Y monthly)0.69
PE ratio (TTM)22.68
EPS (TTM)6.36
Earnings date26 Jan 2021
Forward dividend & yield4.04 (2.78%)
Ex-dividend date23 Nov 2020
1y target est166.18
  • Investors Betting on a Coronavirus Vaccine Better Know Who Gets First Dibs in Global Pact
    Motley Fool

    Investors Betting on a Coronavirus Vaccine Better Know Who Gets First Dibs in Global Pact

    The World Health Organization is managing a global vaccine program without U.S. participation, and it could have a big impact for investors.

  • Warren Buffett's 11 Longest-Held Stocks
    Motley Fool

    Warren Buffett's 11 Longest-Held Stocks

    Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) CEO Warren Buffett has a knack for making himself, and his shareholders, a lot of money. Since 1965, Berkshire Hathaway stock has averaged a compound annual gain of 20.3%, which works out to an aggregate gain of 2,744,062% over the past 55 years. While investors often point to the Oracle of Omaha's ability to find value in plain sight, as well as his focus on businesses with sustainable competitive advantages, maybe the most important puzzle piece to Buffett's success has been his willingness to buy great companies and hold them for very long periods of time.

  • Motley Fool

    What's the Best Way to Invest in Coronavirus Vaccine Stocks?

    In this Fool Live video, Healthcare and Cannabis Bureau Chief Corinne Cardina and longtime Motley Fool contributor Keith Speights discuss several investing strategies to potentially profit from coronavirus vaccine stocks. Corinne Cardina: I'm going to ask you about strategies for investing in the coronavirus vaccine. You could buy a basket with some of the phase three companies that one from each of the different vaccine technologies.